Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 2
1999 1
2006 2
2008 1
2011 1
2012 1
2013 2
2014 3
2015 4
2016 3
2017 1
2019 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean mr tehrani (24 results)?
Pancreatic duct abnormalities in focal autoimmune pancreatitis: MR/MRCP imaging findings.
Negrelli R, Manfredi R, Pedrinolla B, Boninsegna E, Ventriglia A, Mehrabi S, Frulloni L, Pozzi Mucelli R. Negrelli R, et al. Eur Radiol. 2015 Feb;25(2):359-67. doi: 10.1007/s00330-014-3371-y. Epub 2014 Aug 9. Eur Radiol. 2015. PMID: 25106489
AIM: To evaluate the magnetic resonance (MR) imaging-MR cholangiopancreatographic (MRCP) findings of focal forms of autoimmune pancreatitis (AIP) to describe ductal involvement at diagnosis. METHODS: MR examinations of 123 patients affected by AIP were analys …
AIM: To evaluate the magnetic resonance (MR) imaging-MR cholangiopancreatographic (MRCP) findings of focal forms of autoimmune …
Review of the clinical experience with a modified release form of tacrolimus [FK506E (MR4)] in transplantation.
Wente MN, Sauer P, Mehrabi A, Weitz J, Büchler MW, Schmidt J, Schemmer P. Wente MN, et al. Clin Transplant. 2006;20 Suppl 17:80-4. doi: 10.1111/j.1399-0012.2006.00605.x. Clin Transplant. 2006. PMID: 17100706 Review.
To improve the patients' compliance to the prescribed immunosuppressive therapy, FK506E (MR4), a modified release (MR) oral dosage form of tacrolimus has been developed for a once-daily dosing regimen. This report reviews the most recent results of clinical trials with …
To improve the patients' compliance to the prescribed immunosuppressive therapy, FK506E (MR4), a modified release (MR) oral dosage fo …
Mucinous cystic neoplasms and serous cystadenomas arising in the body-tail of the pancreas: MR imaging characterization.
Manfredi R, Ventriglia A, Mantovani W, Mehrabi S, Boninsegna E, Zamboni G, Salvia R, Pozzi Mucelli R. Manfredi R, et al. Eur Radiol. 2015 Apr;25(4):940-9. doi: 10.1007/s00330-014-3493-2. Epub 2014 Nov 23. Eur Radiol. 2015. PMID: 25417125
PURPOSE: To identify magnetic resonance (MR)/MR cholangiopancreatography (MRCP) imaging signs helpful in the differential diagnosis between serous cystadenomas (SCAs) and mucinous cystic neoplasms (MCNs), arising from the body/tail of the pancreas. ...Fifty-three pa …
PURPOSE: To identify magnetic resonance (MR)/MR cholangiopancreatography (MRCP) imaging signs helpful in the differential diag …
Incidentally discovered benign pancreatic cystic neoplasms not communicating with the ductal system: MR/MRCP imaging appearance and evolution.
Manfredi R, Bonatti M, D'Onofrio M, Mehrabi S, Salvia R, Mantovani W, Pozzi Mucelli R. Manfredi R, et al. Radiol Med. 2013 Mar;118(2):163-80. doi: 10.1007/s11547-012-0837-3. Epub 2012 Jun 28. Radiol Med. 2013. PMID: 22744342
PURPOSE: The authors sought to determine magnetic resonance/magnetic resonance cholangiopancreatography (MR/MRCP) imaging features of incidentally discovered benign, noncommunicating cystic neoplasms (BNCNs) of the pancreas to assess their evolution over time and identify …
PURPOSE: The authors sought to determine magnetic resonance/magnetic resonance cholangiopancreatography (MR/MRCP) imaging features of …
Subtyping of hepatocellular adenomas using Gd-EOB-DTPA: a qualitative and quantitative analysis.
Schaible J, Schreyer AG, Mehrabi A, Longerich T, Kieser M, Kreimeyer S, Klauss M, Grenacher L. Schaible J, et al. Acta Radiol. 2023 Jul;64(7):2253-2260. doi: 10.1177/02841851221149197. Epub 2023 Jan 17. Acta Radiol. 2023. PMID: 36650712
BACKGROUND: The goal of medical imaging is not only to identify the entity "hepatocellular adenoma," but to detect typical magnetic resonance (MR) patterns of the subtypes so that lesions with a higher malignant transformation rate could be differentiated from those that s …
BACKGROUND: The goal of medical imaging is not only to identify the entity "hepatocellular adenoma," but to detect typical magnetic resonanc …
IVIM-diffusion-MRI for the differentiation of solid benign and malign hypervascular liver lesions-Evaluation with two different MR scanners.
Klauss M, Mayer P, Maier-Hein K, Laun FB, Mehrabi A, Kauczor HU, Stieltjes B. Klauss M, et al. Eur J Radiol. 2016 Jul;85(7):1289-94. doi: 10.1016/j.ejrad.2016.04.011. Epub 2016 Apr 16. Eur J Radiol. 2016. PMID: 27235876
In this study we evaluated IVIM-derived parameters in HCC and FNH with two different MR-scanners. MATERIAL AND METHODS: 72 patients (29 FNH, 43HCC) were examined prospectively using two 1.5 T-MRI scanners (Aera/MagnetomAvanto, Siemens, Germany). ...The mean values for sign …
In this study we evaluated IVIM-derived parameters in HCC and FNH with two different MR-scanners. MATERIAL AND METHODS: 72 patients ( …
Visualization of intrarenal vessels by 3.0-T MR angiography in comparison with digital subtraction angiography using renal specimens.
Schenk JP, Friebe B, Ley S, Baudendistel K, Schoebinger M, Hähnel S, Mehrabi A, Tröger J, Hallscheidt P. Schenk JP, et al. Pediatr Radiol. 2006 Oct;36(10):1075-81. doi: 10.1007/s00247-006-0274-3. Epub 2006 Aug 9. Pediatr Radiol. 2006. PMID: 16896692
BACKGROUND: MRI at 3.0 T enables high-spatial resolution for renal MR angiography. OBJECTIVE: Evaluation of an arterial tree model in animal kidney specimens with comparison of digital subtraction angiography (DSA) and high-field MRI to find out the maximum spatial resolut …
BACKGROUND: MRI at 3.0 T enables high-spatial resolution for renal MR angiography. OBJECTIVE: Evaluation of an arterial tree model in …
LMTK3 escapes tumour suppressor miRNAs via sequestration of DDX5.
Jacob J, Favicchio R, Karimian N, Mehrabi M, Harding V, Castellano L, Stebbing J, Giamas G. Jacob J, et al. Cancer Lett. 2016 Mar 1;372(1):137-46. doi: 10.1016/j.canlet.2015.12.026. Epub 2015 Dec 29. Cancer Lett. 2016. PMID: 26739063
18 results